powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1417275652
John Allen
M.D.
Hematology-Oncology
Oxford,
MS
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
1,742
Beneficiaries
—
Total drug cost
$3.4M
Distinct drugs
42
Brand share
32.4%
Top prescribed drugs
Letrozole
142 claims
Potassium Chloride
136 claims
Tamoxifen Citrate
116 claims
Ondansetron
112 claims
Hydrocodone/Acetaminophen
83 claims
QUALITY · MIPS · 2024
Final MIPS score
81.9
Quality
64.8
Cost
74.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
190
By payment type
Food and Beverage
$3K
Education
$142
Top paying entities
Food and Beverage
$3K
Education
$142
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,238
Unique beneficiaries
—
Total services
2,551
Distinct HCPCS
11
Medicare payment
$119K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 52 Hematology-Oncology providers in MS — above median (cohort median 1,630).
